
|Articles|May 24, 2019
ICON Acquires MeDiNova Research in Europe and Africa
Advertisement
ICON plc has announced that it has acquired a majority shareholding in MeDiNova Research, a site network with research sites in Europe and Africa, and that it has the right to acquire the remaining shares in the company by Quarter Three 2020. MeDiNova Research currently has a network of 33 active clinical research sites in the UK, Spain, South Africa, Poland and Romania.
For more information click
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Lab Orchestration Is Not What You Think It Is
2
Why Seizure Counts Alone Can't Define Success in Epilepsy Trials
3
ACT Brief: Patient Voice in Protocol Design, AI-Informed Recruitment Workflows, and Engagement Maturity Beyond Performative
4
What It Actually Means to Embed the Patient Voice in Trial Design
5




